GlobalRPh RX List - Intuniv
- Product / population
- Guanfacine extended-release; do not transfer to immediate-release tablets.
- Renal measure
- Qualitative significant renal impairment; no numeric reduction specified.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
A dose reduction may be necessary with significant renal impairment. The source does not specify a fixed renal dose-reduction percentage. Pediatric renal pharmacokinetics have not been assessed. Adult renal clearance falls with declining kidney function; dialysis contributes only about 15% of total clearance. That clearance figure is not a supplemental-dose instruction.